微信小陈
微信小章
产品简介
购买须知
| 产品名称： | Streptomyces lavendulae subsp. lavendulae (Waksman and Curtis) Waksman and Henrici |
|---|---|
| 商品货号： | TS189846 |
| Strain Designations： | MD4-C1 FERM-P 3723 |
| Application： | Produces esterastin |
| Isolation： | Soil, Tokyo, Japan |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Storage Conditions： | 2°C to 8°C |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Type Strain： | no |
| Medium： | ATCC® Medium 196: Yeast malt extract agar ATCC® Medium 1877: ISP Medium 1 |
| Growth Conditions： | Temperature: 26.0°C Atmosphere: xa0 Aerobicxa0 |
| Name of Depositor： | Inst. Microb. Chem. |
| U.S. Patent Number： | |
| References： | Umezawa H, et al. Physiologically active substance esterastin. US Patent 4,189,438 dated Feb 19 1980 Aoyagi T, et al. Cultivating Streptomyces to produce an esterase inhibitor. US Patent 4,242,453 dated Dec 30 1980 |